{"id":"https://openalex.org/W1978189564","doi":"https://doi.org/10.1177/1479164114563304","title":"Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor","display_name":"Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor","alternate_titles":[],"publication_year":2015,"publication_date":"2015-02-17","ids":{"openalex":"https://openalex.org/W1978189564","doi":"https://doi.org/10.1177/1479164114563304","mag":"1978189564","pmid":"https://pubmed.ncbi.nlm.nih.gov/25690134"},"language":"en","primary_location":{"id":"doi:10.1177/1479164114563304","doi":"https://doi.org/10.1177/1479164114563304","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1479164114563304","pdf_url":null,"source":{"id":"https://openalex.org/S115869145","display_name":"Diabetes and Vascular Disease Research","issn_l":"1479-1641","issn":["1479-1641","1752-8984"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes and Vascular Disease Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978189564"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075068326","display_name":"Pablo Lapuerta","orcid":"https://orcid.org/0000-0003-0704-0251","observed_orcids":["https://orcid.org/0000-0003-0704-0251"]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pablo Lapuerta","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210094785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041036914","display_name":"Brian Zambrowicz","orcid":"https://orcid.org/0000-0001-8831-0406","observed_orcids":["https://orcid.org/0000-0001-8831-0406"]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brian Zambrowicz","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210094785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053324412","display_name":"Paul Strumph","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Strumph","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210094785"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108646610","display_name":"Arthur Sands","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arthur Sands","raw_affiliation_strings":["Baylor College of Medicine, Houston, TX, USA","Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc., Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210094785"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2100,"currency":"USD","value_usd":2100},"apc_paid":null,"fwci":1.8883,"has_fulltext":false,"cited_by_count":134,"citation_normalized_percentile":{"value":0.87966252,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"12","issue":"2","first_page":"101","last_page":"110"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotagliflozin","display_name":"sotagliflozin","score":1.0},{"id":"https://openalex.org/keywords/sglt1-inhibition","display_name":"SGLT1 inhibition","score":0.7590000033378601},{"id":"https://openalex.org/keywords/sglt2-inhibition","display_name":"SGLT2 inhibition","score":0.9950000047683716},{"id":"https://openalex.org/keywords/diabetes-treatment","display_name":"diabetes treatment","score":0.6830000281333923},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.7950000166893005},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9929999709129333},{"id":"https://openalex.org/keywords/urinary-glucose-excretion","display_name":"urinary glucose excretion","score":0.9900000095367432},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9580000042915344},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9179999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7961208820343018},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.7655291557312012},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.641721248626709},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.6086174249649048},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5858922600746155},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4946894347667694},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.453821063041687},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4488376975059509},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4188668429851532},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39454102516174316},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3318469822406769},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1185939610004425},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10335001349449158},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.05931621789932251}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051269","descriptor_name":"Sodium-Glucose Transporter 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051269","descriptor_name":"Sodium-Glucose Transporter 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065608","descriptor_name":"Renal Reabsorption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D065667","descriptor_name":"Renal Elimination","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1479164114563304","doi":"https://doi.org/10.1177/1479164114563304","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1479164114563304","pdf_url":null,"source":{"id":"https://openalex.org/S115869145","display_name":"Diabetes and Vascular Disease Research","issn_l":"1479-1641","issn":["1479-1641","1752-8984"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes and Vascular Disease Research","raw_type":"journal-article"},{"id":"pmid:25690134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25690134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes & vascular disease research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1484963749","https://openalex.org/W1979283687","https://openalex.org/W1979377480","https://openalex.org/W2011184145","https://openalex.org/W2036834667","https://openalex.org/W2039880240","https://openalex.org/W2044703739","https://openalex.org/W2049490211","https://openalex.org/W2052764225","https://openalex.org/W2058969403","https://openalex.org/W2064130493","https://openalex.org/W2070768644","https://openalex.org/W2071277783","https://openalex.org/W2072812733","https://openalex.org/W2073526927","https://openalex.org/W2092168940","https://openalex.org/W2100090810","https://openalex.org/W2102203530","https://openalex.org/W2109662292","https://openalex.org/W2119843247","https://openalex.org/W2123775627","https://openalex.org/W2124282046","https://openalex.org/W2127854619","https://openalex.org/W2133469996","https://openalex.org/W2149185387","https://openalex.org/W2152470488","https://openalex.org/W2155287847","https://openalex.org/W2165563030","https://openalex.org/W2170695489","https://openalex.org/W4229984599"],"related_works":["https://openalex.org/W2362680568","https://openalex.org/W2933723988","https://openalex.org/W2797574742","https://openalex.org/W2115247225","https://openalex.org/W2336626166","https://openalex.org/W2809312083","https://openalex.org/W4415018400","https://openalex.org/W2739456155","https://openalex.org/W2151345870","https://openalex.org/W2941322748"],"abstract_inverted_index":{"The":[0,94],"sodium-dependent":[1],"glucose":[2,109,119],"transporter":[3],"2":[4,141],"(SGLT2)":[5],"inhibitors":[6,20],"are":[7],"an":[8,56],"important":[9],"emerging":[10],"class":[11],"for":[12,27,30,127],"the":[13,31,36,128,133],"treatment":[14,134],"of":[15,18,90,98,101,112,130,135],"diabetes.":[16,62,79,142],"Development":[17],"SGLT2":[19,32,66,104],"has":[21,47,83],"been":[22,84],"oriented":[23],"around":[24],"a":[25,69,87,106],"desire":[26],"high":[28],"selectivity":[29],"protein":[33],"relative":[34],"to":[35,60,77],"SGLT1":[37,51,64,91,102],"protein.":[38],"More":[39],"recently,":[40],"genetic":[41],"and":[42,65,92,103,116,139],"pharmacology":[43],"research":[44],"in":[45,68,132],"mice":[46],"indicated":[48],"that":[49],"gastrointestinal":[50],"inhibition":[52,67],"may":[53,123],"also":[54],"be":[55],"appropriate":[57],"therapeutic":[58],"target":[59],"treat":[61,78],"Combining":[63],"single":[70],"molecule":[71],"would":[72],"provide":[73],"complementary":[74],"insulin-independent":[75],"mechanisms":[76],"Therefore,":[80],"sotagliflozin":[81,131],"(LX4211)":[82],"developed":[85],"as":[86],"dual":[88,99],"inhibitor":[89,100],"SGLT2.":[93],"differentiating":[95],"clinical":[96,125],"features":[97,122],"include":[105],"large":[107],"postprandial":[108],"reduction,":[110],"elevation":[111],"glucagon-like":[113],"peptide":[114],"1":[115,138],"modest":[117],"urinary":[118],"excretion.":[120],"These":[121],"have":[124],"implications":[126],"use":[129],"both":[136],"type":[137,140]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978189564","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":20},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
